OUR TECHNOLOGY
At Lytos Therapeutics, we believe that pain treatment should be targeted and patient-centered - minimally invasive and drug-free. Our commitment to innovation has led to the creation of SoluSphere™, a next-generation platform being developed to address musculoskeletal pain.
SoluSphere™ Is More Than a Material
SoluSphere™ represents an innovative approach under development to enable physicians and interventional radiologists to perform image-guided procedures in outpatient settings. Early feasibility clinical research with an earlier prototype demonstrated the promise of this approach and informed the design of SoluSphere™. By combining ease of use with engineered degradation characteristics and design flexibility, SoluSphere™ aims to support the exploration of new, minimally invasive approaches for vascular-targeted interventions in musculoskeletal health, including conditions such as osteoarthritis and tendinopathy, which affect over a billion people globally.
IMAGE GUIDED
Advancing image-guided approaches in musculoskeletal (MSK) care to expand potential use beyond the interventional radiology suite and into office-based clinical settings for qualified practitioners
SPORTS MEDICINE TO ORTHOPEDICS
Developed to support applications across disciplines - from sports medicine to orthopedics - in advancing patient care and pain management practices
DESIGNED WITH BROAD POTENTIAL
Engineered with the flexibility to enable future, highly targeted applications in areas such as uterine fibroids, prostate, brain, and other hypervascular conditions
SoluSphere™ is not cleared or approved for commercial use in the United States or other markets.
Osteoarthritis (OA) and Tendinopathy (TDNPY): Affects Over 1 Billion Sufferers Globally
1.https://doi.org/10.1016/j.joca.2024.07.014
3.Sources: World Health Organisation (WHO) and Global Burden of Disease Study 2019
Osteoarthritis
Tendinopathy
We’re not just building technology. We’re building a future where pain management is more accessible, personalized and transformative.
Our ultrasound-guided technology has the potential to empower practitioners to deliver precise, targeted therapies under image guidance. Ultrasound visibility positions it for future scalability and advancement aimed at making minimally invasive pain management more accessible worldwide. This opens new possibilities for exploring non-surgical approaches to musculoskeletal care, particularly in underserved regions where reliable solutions are urgently needed.
